Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-11-004910
Filing Date
2011-12-14
Accepted
2011-12-14 15:40:27
Documents
2
Period of Report
2011-12-06

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 1453
2 POWER OF ATTORNEY ex24.htm EX-24 3918
  Complete submission text file 0001062993-11-004910.txt   6737
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Issuer) CIK: 0000875622 (see all company filings)

EIN.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PROTINE DESIGN LAB 34801 CAMPUS DR FREEMONT CA 94555
Business Address
GOULD GEORGE M (Reporting) CIK: 0001242115 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34236 | Film No.: 111261114